Previous close | 108,200.00 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 100,220.00 - 100,220.00 |
52-week range | 85,081.00 - 117,270.00 |
Volume | |
Avg. volume | 2 |
Market cap | N/A |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | 23,263.70 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Abbott's (ABT) glucose monitoring systems - Lingo and Libre Rio - based on Freestyle Libre technology, receive FDA clearance.
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
A New York Stock Exchange glitch showed erroneous prices for several stocks, including Berkshire Hathaway class A shares (BRK-A), which were shown to be down 99.9%. The issue has since been resolved. In the video above, Yahoo Finance's Jared Blikre breaks down what happened on Wall Street today. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Stephanie Mikulich.